Knowler J T
Int Rev Cytol. 1983;84:103-53. doi: 10.1016/s0074-7696(08)61016-5.
This article has sought to draw together, on the one hand, what is known of mRNA processing and its control and, on the other hand, what is known of the structure and validity of hnRNP and snRNP particles. At the same time, it has attempted to synthesize these two themes into a critical assessment of the evidence which suggests that the particles are intimately involved in processing. It cannot be said that the case is proven. The evidence is compelling but circumstantial. The last few years have seen the development of the first in vitro splicing systems (Weingartner and Keller, 1981; Goldenberg and Raskus, 1981; Kole and Weissman, 1982), the isolation of monoclonal antibodies to defined snRNP (Lerner et al., 1981a; Billings et al., 1982) and hnRNP proteins (Hugle et al., 1982), and the ability to use artificial lipid vesicles to transfer antisera (Lenk et al., 1982) and radioactive snRNA (Gross and Cetron, 1982) into cells. It is to be hoped that further refinements of these and other techniques will allow us to solve this, one of the major outstanding problems of molecular biology.
本文一方面试图汇总关于mRNA加工及其调控的已知信息,另一方面汇总关于hnRNP和snRNP颗粒的结构及有效性的已知信息。同时,本文还尝试将这两个主题综合起来,对表明这些颗粒密切参与加工过程的证据进行批判性评估。目前还不能说这个观点已被证实。证据很有说服力,但属于间接证据。在过去几年里,第一代体外剪接系统得到了发展(温加特纳和凯勒,1981年;戈尔登贝格和拉斯库斯,1981年;科尔和魏斯曼,1982年),针对特定snRNP(勒纳等人,1981a;比林斯等人,1982年)和hnRNP蛋白(胡格勒等人,1982年)的单克隆抗体被分离出来,并且能够利用人工脂质囊泡将抗血清(伦克等人,1982年)和放射性snRNA(格罗斯和塞特龙,1982年)导入细胞。希望这些技术和其他技术的进一步完善将使我们能够解决这个分子生物学中主要的突出问题之一。